DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $757,000 | +5.9% | 145,577 | -4.9% | 0.00% | – |
| Q3 2016 | $715,000 | +18.6% | 153,052 | 0.0% | 0.00% | – |
| Q2 2016 | $603,000 | +30.2% | 153,052 | +2.4% | 0.00% | – |
| Q1 2016 | $463,000 | -32.2% | 149,439 | 0.0% | 0.00% | – |
| Q4 2015 | $683,000 | +64.2% | 149,439 | +69.2% | 0.00% | – |
| Q3 2015 | $416,000 | -19.4% | 88,317 | +22.6% | 0.00% | – |
| Q2 2015 | $516,000 | -73.0% | 72,045 | -68.0% | 0.00% | – |
| Q1 2015 | $1,910,000 | -9.2% | 225,474 | -0.2% | 0.00% | – |
| Q4 2014 | $2,103,000 | +9.1% | 225,888 | -2.3% | 0.00% | – |
| Q3 2014 | $1,927,000 | -31.9% | 231,304 | -5.5% | 0.00% | – |
| Q2 2014 | $2,830,000 | +4.5% | 244,818 | +14.6% | 0.00% | – |
| Q1 2014 | $2,709,000 | +87.1% | 213,644 | +59.6% | 0.00% | – |
| Q4 2013 | $1,448,000 | -22.2% | 133,862 | -11.0% | 0.00% | – |
| Q3 2013 | $1,862,000 | -2.5% | 150,442 | +5.2% | 0.00% | – |
| Q2 2013 | $1,909,000 | – | 143,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,994,876 | $24,697,000 | 2.58% |
| Broadfin Capital, LLC | 771,598 | $9,552,000 | 1.70% |
| Raging Capital Management, LLC | 698,401 | $8,646,000 | 1.49% |
| Camber Capital Management LP | 950,000 | $11,761,000 | 1.23% |
| DAFNA Capital Management LLC | 57,009 | $706,000 | 0.77% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 44,027 | $545,000 | 0.67% |
| Baker Brothers Advisors | 2,558,857 | $31,679,000 | 0.45% |
| THB ASSET MANAGEMENT | 430,810 | $5,333,000 | 0.33% |
| EAM Investors, LLC | 100,658 | $1,246,000 | 0.25% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 32,741 | $390,000 | 0.19% |